Table 2. Open in new tab Risk of Bias of... | Oxford Academic

Table 2.

Open in new tab

Risk of Bias of Included Studies

Study	Random Sequence Generation	Allocation Concealment	Blinding of Participants and Personnel	Blinding of Outcome Assessment		Incomplete Outcome Data		Selective Reporting	Loss to Follow-Up, %
				PRO	AEO	PRO	AEO
Brock et al., 2016	Low risk	Low risk	Low risk	Unclear	Low risk	High risk	Low risk	Low risk	16.1
Snyder et al., 2016	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	4.8
Paduch et al., 2015	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	13

Study	Random Sequence Generation	Allocation Concealment	Blinding of Participants and Personnel	Blinding of Outcome Assessment		Incomplete Outcome Data		Selective Reporting	Loss to Follow-Up, %
				PRO	AEO	PRO	AEO
Brock et al., 2016	Low risk	Low risk	Low risk	Unclear	Low risk	High risk	Low risk	Low risk	16.1
Snyder et al., 2016	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	4.8
Paduch et al., 2015	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	13

				Patient Reported Outcomes
Steidle et al., 2003	Unclear	Unclear	Low risk	Low risk		Unclear		High risk	28.6

Abbreviations: AEO, adverse events outcomes; PRO, patient reported outcomes.

Table 2.

Open in new tab

Risk of Bias of Included Studies

Study	Random Sequence Generation	Allocation Concealment	Blinding of Participants and Personnel	Blinding of Outcome Assessment		Incomplete Outcome Data		Selective Reporting	Loss to Follow-Up, %
				PRO	AEO	PRO	AEO
Brock et al., 2016	Low risk	Low risk	Low risk	Unclear	Low risk	High risk	Low risk	Low risk	16.1
Snyder et al., 2016	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	4.8
Paduch et al., 2015	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	13

Study	Random Sequence Generation	Allocation Concealment	Blinding of Participants and Personnel	Blinding of Outcome Assessment		Incomplete Outcome Data		Selective Reporting	Loss to Follow-Up, %
				PRO	AEO	PRO	AEO
Brock et al., 2016	Low risk	Low risk	Low risk	Unclear	Low risk	High risk	Low risk	Low risk	16.1
Snyder et al., 2016	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	4.8
Paduch et al., 2015	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	Low risk	13

				Patient Reported Outcomes
Steidle et al., 2003	Unclear	Unclear	Low risk	Low risk		Unclear		High risk	28.6

Abbreviations: AEO, adverse events outcomes; PRO, patient reported outcomes.